 effect recombin human aplast anemia phase i/ii studi patient aplast anemia recombin human toxic biolog effect multipotenti hematopoiet growth factor subcutan bolu inject day increas platelet count patient increas reticulocyt count patient blood leukocyt patient median due increas number neutrophil eosinophil lymphocyt monocyt patient bone marrow cellular substanti improv peripher blood count mild side effect headach flush patient low-grad fever patient transient thrombocytopenia discontinu treatment patient conclus hematopoiesi patient aplast anemia last effect